Connie Raif, CEO of Doktorhuus Gruppe AG, added: "The divestment of our two renowned outpatient institutes in Baden allows us to streamline our medical service portfolio and refocus entirely on our core expertise in general practitioner medicine. During our ownership, we successfully addressed succession matters and established a highly skilled and entrepreneurial team of doctors. Our commitment to advanced medical technology, patient-friendly environments, and the highest medical standards has been evident throughout. I am convinced that Affidea is the ideal new owner of these two centres, ensuring continuity, and providing added value for the team, patients and the entire region of Baden.

This is the third investment Affidea has announced this year in Switzerland, after the announcement of opening a breast centre in Ticino, which will allow Affidea to expand its expertise in the areas of prevention, diagnosis, treatment and monitoring of breast cancer. Recently, Affidea also announced important investments in state-of-the-art equipment in the Valais region to enhance the capabilities of its medical facilities. The Affidea Sion centre inaugurated its nuclear medicine unit with new state-of-the-art equipment, the Spect-CT scanner and the 1.5 T MRI which will allow patients to have access to tomo-scintigraphy examinations, while the Women's Centre in Sion started offering MRI-guided biopsy and bone densitometry.


With this acquisition in Baden, Affidea reaches 358 centres at the European level, working with more than 14.000 professionals and serving over 13 million patients every year. Only this year, Affidea has announced an impressive growth journey with expansions in Spain, Portugal, Romania, Italy and now Switzerland.
In this transaction, Affidea Group was advised by Niederer Kraft Frey as legal advisors, while KPMG served as financial advisor. The sellers were advised by Sancovia as financial advisors and Walder Wyss as legal advisors.


About Affidea Switzerland
Affidea is present in Switzerland since 2007 and annually offers its medical services to more than 150,000 patients. In French-speaking Switzerland, Affidea owns 11 medical imaging centres located in the regions of Fribourg, Valais, and Geneva, including two centres specialising in women's imaging. In the German-speaking Switzerland, Affidea acquired two integrated breast care centres in 2022, Brust-Zentrum Zurich and Plastic Surgery Group, and the recently established Brust-Zentrum Ticino following the Zurich model. Affidea Switzerland brings together more than 300 specialists in a total of 14 centres and more than 60 doctors. The company is recognised for its patient safety approach, and its diagnostic centres have been awarded the 5-stars for patient safety on the Eurosafe Wall of Stars by the European Society of Radiology."

Business Affairs Homepage